StockData
Penumbra Inc logo

Penumbra Inc (PEN) stock

PENNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3074% above fair value
$320.62−0.29 (-0.09%)

Close on Nov 16, 2026Market cap $12.64BP/E 80.8Yield –

Penumbra ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Penumbra's ebitda for the twelve months ending Sep 30, 2026 was $209.36M, up 10.1% year over year. For fiscal 2025 it was $206.72M, up 526.8% from the year before. Over ten years it grew 42.6% a year on average. The highest annual figure on record is $206.72M in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$206.72M+526.8%
FY2024Dec 31, 2024$32.98M-67.3%
FY2023Dec 31, 2023$100.81M+231.6%
FY2022Dec 31, 2022$30.40M+241.3%
FY2021Dec 31, 2021$8.91M–
FY2020Dec 31, 2020-$26.05M-146.8%
FY2019Dec 31, 2019$55.61M+946.1%
FY2018Dec 31, 2018$5.32M+7.5%
FY2017Dec 31, 2017$4.95M+422.3%
FY2016Dec 31, 2016$947.00K-84.0%
FY2015Dec 31, 2015$5.93M+57.7%
FY2014Dec 31, 2014$3.76M–
FY2013Dec 31, 2013-$449.00K–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$56.21M+9.5%
Q2 FY2026Jun 30, 2026$46.65M+0.7%
Q1 FY2026Mar 31, 2026$42.81M-5.6%
Q4 FY2025Dec 31, 2025$63.69M+35.1%
Q3 FY2025Sep 30, 2025$51.33M+29.9%
Q2 FY2025Jun 30, 2025$46.34M–
Q1 FY2025Mar 31, 2025$45.37M+131.2%
Q4 FY2024Dec 31, 2024$47.16M+12.1%
Q3 FY2024Sep 30, 2024$39.51M+102.0%
Q2 FY2024Jun 30, 2024-$73.31M-398.0%
Q1 FY2024Mar 31, 2024$19.62M+34.5%
Q4 FY2023Dec 31, 2023$42.07M+273.1%
Q3 FY2023Sep 30, 2023$19.56M+67.8%
Q2 FY2023Jun 30, 2023$24.60M+324.9%
Q1 FY2023Mar 31, 2023$14.58M+768.0%
Q4 FY2022Dec 31, 2022$11.27M–
Q3 FY2022Sep 30, 2022$11.66M-6.1%
Q2 FY2022Jun 30, 2022$5.79M-58.2%
Q1 FY2022Mar 31, 2022$1.68M-90.1%
Q4 FY2021Dec 31, 2021-$34.30M-2102.6%
Q3 FY2021Sep 30, 2021$12.41M–
Q2 FY2021Jun 30, 2021$13.86M–
Q1 FY2021Mar 31, 2021$16.93M+374.5%
Q4 FY2020Dec 31, 2020$1.71M-86.7%
Q3 FY2020Sep 30, 2020-$16.82M-211.9%
Q2 FY2020Jun 30, 2020-$14.52M-198.5%
Q1 FY2020Mar 31, 2020$3.57M-72.5%
Q4 FY2019Dec 31, 2019$12.89M+53.9%
Q3 FY2019Sep 30, 2019$15.03M–
Q2 FY2019Jun 30, 2019$14.73M+36.0%
Q1 FY2019Mar 31, 2019$12.96M+138.0%
Q4 FY2018Dec 31, 2018$8.38M+65.7%
Q3 FY2018Sep 30, 2018-$19.34M-1150.4%
Q2 FY2018Jun 30, 2018$10.83M–
Q1 FY2018Mar 31, 2018$5.44M–
Q4 FY2017Dec 31, 2017$5.06M–
Q3 FY2017Sep 30, 2017$1.84M–
Q2 FY2017Jun 30, 2017-$560.00K–
Q1 FY2017Mar 31, 2017-$1.39M–
Q4 FY2016Dec 31, 2016-$664.00K–

More Penumbra figures

See a number that looks wrong?